The effect of red ginseng extract on inflammatory cytokines after chemotherapy in children

Journal of Ginseng Research

Volumn 36, Issue 4, 2012, Pages 383-390

  Lee, Jae Min ^a   Hah, Jeong Ok ^a   Kim, Hee Sun ^a  

^a Yeungnam University College of Medicine   (South Korea)

Author keywords

Childhood cancer; Cytokine; Korean red ginseng; Panax ginseng

Indexed keywords

EID: 84867678305     PISSN: 12268453     EISSN: None     Source Type: Journal    
DOI: 10.5142/jgr.2012.36.4.383     Document Type: Article

References (34)

1. Mackall CL, Fleisher TA, Brown MR, Magrath IT, Shad AT, Horowitz ME, Wexler LH, Adde MA, McClure LL, Gress RE. Lymphocyte depletion during treatment with intensive chemotherapy for cancer. Blood 1994;84:2221-2228.
2. Borella L, Webster RG. The immunosuppressive effects of long-term combination chemotherapy in children with acute leukemia in remission. Cancer Res 1971;31:420-426.
3. Alanko S, Pelliniemi TT, Salmi TT. Recovery of blood B-lymphocytes and serum immunoglobulins after chemotherapy for childhood acute lymphoblastic leukemia. Cancer 1992;69:1481-1486.
4. Pasino M, Vadala CR, De Bernardi B, Comelli A, Mori PG, Dini G, Bisogni MC, Tonini GP, Massimo L. Im-munological evaluation of 22 patients with acute lympho-blastic leukemia off-therapy. A longitudinal follow-up. Helv Paediatr Acta 1981;36:69-80.
5. De Vaan GA, van Munster PJ, Bakkeren JA. Recovery of immune function after cessation of maintenance therapy in acute lymphoblastic leukemia (ALL) of childhood. Eur J Pediatr 1982;139:113-117.
6. Mustafa MM, Buchanan GR, Winick NJ, McCracken GH, Tkaczewski I, Lipscomb M, Ansari Q, Agopian MS. Immune recovery in children with malignancy after cessation of chemotherapy. J Pediatr Hematol Oncol 1998;20:451-457.
7. Alanko S, Salmi TT, Pelliniemi TT. Recovery of blood T-cell subsets after chemotherapy for childhood acute lym-phoblastic leukemia. Pediatr Hematol Oncol 1994;11:281-292.
8. Alanko S, Salmi TT, Pelliniemi TT. Recovery of natural killer cells after chemotherapy for childhood acute lymphoblastic leukemia and solid tumors. Med Pediatr Oncol 1995;24:373-378.
9. Kim DH. Chemical diversity of Panax ginseng, Panax quinquifolium, and Panax notoginseng. J Ginseng Res 2012;36:1-15.
10. Ernst E. Panax ginseng: An overview of the clinical evidence. J Ginseng Res 2010;34:259-263.
11. Lee ST, Chu K, Sim JY, Heo JH, Kim M. Panax ginseng enhances cognitive performance in Alzheimer disease. Alzheimer Dis Assoc Disord 2008;22:222-226.
12. Cheng JT. Merit of ginseng in the improvement of insulin resistance. J Ginseng Res 2010;34:155-159.
13. Scaglione F, Cattaneo G, Alessandria M, Cogo R. Effcacy and safety of the standardised ginseng extract G115 for potentiating vaccination against the influenza syndrome and protection against the common cold. Drugs Exp Clin Res 1996;22:65-72.
14. Scaglione F, Ferrara F, Dugnani S, Falchi M, Santoro G, Fraschini F. Immunomodulatory effects of two extracts of Panax ginseng C.A. Meyer. Drugs Exp Clin Res 1990;16:537-542.
15. The Korea Central Cancer Registry, National Cancer Center. 2008 Annual report of cancer statistics in Korea. Seoul: Ministry of Health and Welfare, 2010.
16. Nathan PC, Greenberg ML, Ness KK, Hudson MM, Mertens AC, Mahoney MC, Gurney JG, Donaldson SS, Leisenring WM, Robison LL et al. Medical care in long-term survivors of childhood cancer: a report from the childhood cancer survivor study. J Clin Oncol 2008;26:4401-4409.
17. Oeffinger KC, Mertens AC, Sklar CA, Kawashima T, Hudson MM, Meadows AT, Friedman DL, Marina N, Hobbie W, Kadan-Lottick NS et al. Chronic health conditions in adult survivors of childhood cancer. N Engl J Med 2006;355:1572-1582.
18. Plevova P. Radiotherapy- and chemotherapy-induced normal tissue damage. Radiol Oncol 2002;36:109-119.
19. Mazur B, Mertas A, Sonta-Jakimczyk D, Szczepanski T, Janik-Moszant A. Concentration of IL-2, IL-6, IL-8, IL-10 and TNF-alpha in children with acute lymphoblastic leukemia after cessation of chemotherapy. Hematol Oncol 2004;22:27-34.
20. Martin K, Viera K, Petr C, Marie N, Eva T. Simultaneous analysis of cytokines and co-stimulatory molecules concentrations by ELISA technique and of probabilities of measurable concentrations of interleukins IL-2, IL-4, IL-5, IL-6, CXCL8 (IL-8), IL-10, IL-13 occurring in plasma of healthy blood donors. Mediators Inflamm 2006;2006:65237.
21. Berdat PA, Wehrle TJ, Kung A, Achermann F, Sutter M, Carrel TP, Nydegger UE. Age-specifc analysis of normal cytokine levels in healthy infants. Clin Chem Lab Med 2003;41:1335-1339.
22. Hamza T, Barnett JB, Li B. Interleukin 12 a key immunoregulatory cytokine in infection applications. Int J Mol Sci 2010;11:789-806.
23. Schroder K, Hertzog PJ, Ravasi T, Hume DA. Interferon-gamma: an overview of signals, mechanisms and functions. J Leukoc Biol 2004;75:163-189.
24. Niederwieser D, Herold M, Woloszczuk W, Aulitzky W, Meister B, Tilg H, Gastl G, Bowden R, Huber C. Endogenous IFN-gamma during human bone marrow transplantation. Analysis of serum levels of interferon and interferon-dependent secondary messages. Transplantation 1990;50:620-625.
25. Kim SK, Park JH. Trends in ginseng research in 2010. J Ginseng Res 2011;35:389-398.
26. Park EK, Choo MK, Kim EJ, Han MJ, Kim DH. Antiallergic activity of ginsenoside Rh2. Biol Pharm Bull 2003;26:1581-1584.
27. Park JS, Shin JA, Jung JS, Hyun JW, Van Le TK, Kim DH, Park EM, Kim HS. Anti-inflammatory mechanism of compound K in activated microglia and its neuroprotective effect on experimental stroke in mice. J Pharmacol Exp Ther 2012;341:59-67.
28. Wang L, Zhang Y, Chen J, Li S, Wang Y, Hu L, Wang L, Wu Y. Immunosuppressive effects of ginsenoside-Rd on skin allograft rejection in rats. J Surg Res 2012;176:267-274.
29. Wu CF, Bi XL, Yang J Y, Zhan JY, Dong YX, Wang JH, Wang JM, Zhang R, Li X. Differential effects of ginsen-osides on NO and TNF-alpha production by LPS-activat-ed N9 microglia. Int Immunopharmacol 2007;7:313-320.
30. Smolinski AT, Pestka JJ. Modulation of lipopolysac-charide-induced proinflammatory cytokine production in vitro and in vivo by the herbal constituents apigenin (chamomile), ginsenoside Rb1 (ginseng) and parthenolide (feverfew). Food Chem Toxicol 2003;41:1381-1390.
31. Xu X, Ling Q, Wei Q, Wang K, Zhou B, Zhuang L, Zhou L, Zheng S. Korean red ginseng: a new approach for the treatment of graft-versus-host disease after liver transplantation. Transplant Proc 2011;43:2651-2655.
32. Suh SO, Boo YJ, Park JM, Kim J. Prospective study for Korean red ginseng extract as an immune modulator following a curative surgery in patients with advanced colon cancer. J Ginseng Res 2007;31:54-59.
33. Kim S, Shim S, Choi DS, Kim JH, Kwon YB, Kwon J. Modulation of LPS-stimulated astroglial activation by ginseng total saponins. J Ginseng Res 2011;35:80-85.
34. Kim EH, Lee MJ, Kim IH, Pyo SN, Choi KT, Rhee DK. Anti-apoptotic effects of red ginseng on oxidative stress induced by hydrogen peroxide in SK-N-SH cells. J Ginseng Res 2010;34:138-144.